The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global minimally invasive surgery market reached a value of US$ 44.2 Billion in 2020. Looking forward, IMARC Group expects the market to exhibit moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A minimally invasive surgery utilizes surgical techniques that limit the size and number of cuts or incisions during an operation with the help of small tools, cameras and lights. This procedure is much safer in nature as compared to traditional open surgery as it results in fewer complications, quicker recovery, minimal blood loss, good results and shorter hospital stays. Due to these factors, these surgeries are gaining popularity amongst surgeons as well as patients all over the world. They are mostly being used for cardiothoracic, orthopedic, vascular and neurological surgical procedures.
The report has also analysed the competitive landscape of the market with some of the key players being Zimmer Biomet Inc., Medtronic Inc., GE Healthcare, Intuitive, Eximis Surgical, Stryker Corporation, Arthrex, B. Braun, Bauer Medical, Check-Cap, Cook Medical, OmniGuide, Inc., Orthofix Holdings,Inc, Pentax, Philips Healthcare, RF System, Smith & Nephew, TransEnterix, Virtual Ports, etc.
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at